Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer

Antitumor Activity of a Combination of rAd2p53 Adenoviral Gene Therapy and Radiotherapy in Esophageal Carcinoma

(2011) Ping Lu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks

(2011) Ashraf Khalil et al.   CELL CYCLE

The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition

(2011) F. Rodel et al.   CURRENT MEDICINAL CHEMISTRY

PKCδ regulates Mdm2 independently of p53 in the apoptotic response to DNA damage

(2011) Hoi Chin Hew et al.   MOLECULAR CARCINOGENESIS

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

(2011) Caroline J. Breitbach et al.   NATURE

A Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition

(2011) Neda Bagheri et al.   PLoS Computational Biology

Oncolytic adenovirus based on serotype 3

(2010) O Hemminki et al.   CANCER GENE THERAPY

Identification of Antrocin from Antrodia camphorata as a Selective and Novel Class of Small Molecule Inhibitor of Akt/mTOR Signaling in Metastatic Breast Cancer MDA-MB-231 Cells

(2010) Yerra Koteswara Rao et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Structural Characterization of HBXIP: The Protein That Interacts with the Anti-Apoptotic Protein Survivin and the Oncogenic Viral Protein HBx

(2010) I. Garcia-Saez et al.   JOURNAL OF MOLECULAR BIOLOGY

Stage-specific sensitivity to p53 restoration during lung cancer progression

(2010) David M. Feldser et al.   NATURE

p53-based Cancer Therapy

(2010) D. P. Lane et al.   Cold Spring Harbor Perspectives in Biology

E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer

(2009) Xiao-Ping He et al.   CANCER LETTERS

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Targeted genetic and viral therapy for advanced head and neck cancers

(2009) Pin-I Huang et al.   DRUG DISCOVERY TODAY

Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma

(2009) Zhi-xiang Yang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

(2009) Albert M Maguire et al.   LANCET

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

(2009) C. W. Christine et al.   NEUROLOGY

Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis

(2009) Artur V. Cideciyan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

(2009) N. Cartier et al.   SCIENCE

p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling

(2008) Andrei V. Budanov et al.   CELL

E2F Promoter-Regulated Oncolytic Adenovirus with p16 Gene Induces Cell Apoptosis and Exerts Antitumor Effect on Gastric Cancer

(2008) J. Ma et al.   DIGESTIVE DISEASES AND SCIENCES

A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers

(2008) Xinghua Wang et al.   MOLECULAR CANCER THERAPEUTICS

Toxicology Profiles of a Novel p53-Armed Replication-Competent Oncolytic Adenovirus in Rodents, Felids, and Nonhuman Primates

(2008) Changqing Su et al.   TOXICOLOGICAL SCIENCES